Christopher Moreau

Algernon Pharmaceuticals Inc.


Mr. Moreau is a seasoned business professional in the life sciences sector with a strong background in biotechnology research, business development and deep expertise in the capital markets. Mr. Moreau was previously President & CEO and Director of a publicly-traded company focused on the research & development of screening tests for prostate cancer, skin cholesterol and type 2 diabetes. He has raised in excess of $30 million from the capital markets and has over 30 years of senior management experience in private & publicly-traded company environments.